Infectious Etiology of Alzheimer's Disease (R01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) will support applications aimed at: (1) determining whether microbial pathogens represent a causal component of Alzheimer’s disease (AD), (2) establishing mechanisms by which microbial pathogens impact neurodegenerative processes in AD, and (3) informing aspects of future translational studies in AD, including the discovery of candidate therapeutics aimed at regulating pathogen-associated networks and molecules in AD.


  • Letter of Intent Due Date(s): February 28, 2021

  • Application Due Date(s): March 31, 2021

RFA-AG-21-034 Expiration Date April 1, 2021




Medical - Basic Science
Medical - Translational

External Deadline

March 31, 2021